Ioversol
![]() | |
Clinical data | |
---|---|
Trade names | Optiray |
AHFS/Drugs.com | Multum Consumer Information |
Pregnancy category |
|
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | Low |
Metabolism | None |
Elimination half-life | 90 min |
Excretion | Kidneys |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.118.911 |
Chemical and physical data | |
Formula | C18H24I3N3O9 |
Molar mass | 807.115 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Ioversol (INN; trade name Optiray) is an organoiodine compound that is used as a contrast medium. It features both a high iodine content, as well as several hydrophilic groups. It is used in clinical diagnostics including arthrography, angiocardiography and urography.[2][3]
References
[edit]- ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
- ^ "Optiray (ioversol) dosing, indications, interactions, adverse effects, and more". reference.medscape.com. Retrieved 9 January 2021.
- ^ Chen Y, Huang X, Huang S, Matchett M (17 February 2011). "13. Fast-in-process method for the determination ioversol and related polar compounds by hydrophilic interactive chromatography". In Wang PG, He W (eds.). Hydrophilic Interaction Liquid Chromatography (HILIC) and Advanced Applications. CRC Press. p. 295-30. ISBN 978-1-4398-0753-8.